A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

2010 ◽  
Vol 60 (2) ◽  
pp. 261-271 ◽  
Author(s):  
Stéphane Oudard ◽  
Olivier Rixe ◽  
Benoit Beuselinck ◽  
Claude Linassier ◽  
Eugeniu Banu ◽  
...  
2016 ◽  
Vol 34 (15_suppl) ◽  
pp. TPS5603-TPS5603 ◽  
Author(s):  
Rosalind Margaret Glasspool ◽  
Iain A. McNeish ◽  
James Paul ◽  
Claire A Lawless ◽  
Diann Taggart ◽  
...  

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS5620-TPS5620 ◽  
Author(s):  
Cristina Martin-Lorente ◽  
David SP Tan ◽  
Neesha Dhani ◽  
Marcus Butler ◽  
Helen Mackay ◽  
...  

2013 ◽  
Vol 13 (2) ◽  
pp. 79-80
Author(s):  
Zane Simtniece ◽  
Gatis Kirsakmens ◽  
Ilze Strumfa ◽  
Andrejs Vanags ◽  
Maris Pavars ◽  
...  

Abstract Here, we report surgical treatment of a patient presenting with pancreatic metastasis (MTS) of renal clear cell carcinoma (RCC) 11 years after nephrectomy. RCC is one of few cancers that metastasise in pancreas. Jaundice, abdominal pain or gastrointestinal bleeding can develop; however, asymptomatic MTS can be discovered by follow-up after removal of the primary tumour. The patient, 67-year-old female was radiologically diagnosed with a clinically silent mass in the pancreatic body and underwent distal pancreatic resection. The postoperative period was smooth. Four months after the surgery, there were no signs of disease progression.


Sign in / Sign up

Export Citation Format

Share Document